CSF3 and lung carcinoma: In the Lewis lung cancer model, all cytokine treatment groups yielded a statistically significant rise in platelet counts as compared to the vehicle control on day 7 (p = 0.01 for G-CSF, and p < 0.001 for all IL-12 treatment groups).